FDA Considering Changes To Risky Drug Safeguards
WASHINGTON (Reuters) - Safeguards to protect patients from risky drugs should have less paperwork and more consistency, drugmakers and pharmacy representatives said this week during a U.S. Food and Drug Administration meeting.